Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high
In a setback to AIDS activists, a federal court jury on Friday cleared Gilead Sciences and Teva Pharmaceuticals of allegations that the companies struck an